B. Enkhmaa

PROFILE

Homepage
No homepage is listed.
ORCID
No ORCID is listed.
Affiliations
No affiliations are listed.
Aliases
B Enkhmaa, B. Enkhmaa, Byambaa Enkhmaa
Publication record
83 papers · 2,691 citations · H-index 24

PAPERS

Asthma and Summary Measure of Social Determinants of Health/Health Equity Among Adults in Mississippi, 2022
20250 citationsauthor #3
Impact of Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitors on Lipoprotein(a)
202514 citationsauthor #9
Association Between Triglyceride to High-Density Lipoprotein Cholesterol Ratio and Insulin Resistance in Mongolian Adults
20250 citationsauthor #6
The Association Between a Summary Measure of Social Determinants of Health/Health Equity and Cardiovascular Disease Burden Among Mississippi Adults
20241 citationsauthor #3
Lipoprotein(a) and diet: consuming sugar-sweetened beverages lowers lipoprotein(a) levels in obese and overweight adults
20243 citationsauthor #10
Safety profile of proprotein convertase subtilisin/kexin type 9 inhibitors alirocumab and evolocumab: an updated meta-analysis and meta-regression
20242 citationsauthor #11
Impaired incretin homeostasis in non-diabetic moderate-severe CKD
20230 citationsauthor #4
Sex Differences in Cardiovascular Outcomes and Cholesterol-Lowering Efficacy of PCSK9 Inhibitors
202322 citationsauthor #8
Lipoprotein(a) and diet—a challenge for a role of saturated fat in cardiovascular disease risk reduction?
202319 citationsauthor #4
Cardiovascular Disease Mortality in Mississippi, 2000–2018
20227 citationsauthor #5
Non-genetic influences on lipoprotein(a) concentrations
2022118 citationsauthor #1
Dietary Management of Heart Failure: DASH Diet and Precision Nutrition Perspectives
202177 citationsauthor #2
Lp(a) and SARS‐CoV‐2: A conspiracy of two mysteries
20211 citationsauthor #1
Lp(a)‐Associated Oxidized Phospholipids in Healthy Black and White Participants in Relation to apo(a) Size, Age, and Family Structure
202112 citationsauthor #7
Temporal Trends in Hypertension Death Rate in Mississippi, 2000-2018.
20213 citationsauthor #6
Diet and Lp(a): Does Dietary Change Modify Residual Cardiovascular Risk Conferred by Lp(a)?
202077 citationsauthor #1
PCSK9 in African Americans and Caucasians in Relation to Lp(a) Level, Apo(a) Size and Heritability
20208 citationsauthor #1
Statins and Lp(a) – the plot thickens
201913 citationsauthor #1
Heritability of apolipoprotein (a) traits in two-generational African-American and Caucasian families[S]
201920 citationsauthor #1
MONGOLIAN STATE POLICY ON LITERACY – FROM 1921 TO PRESENT
20190 citationsauthor #2
Molecular Nutrition Fats
20191 citationsauthor #1
Food Insecurity and Cardiovascular Disease Risk Factors among Mississippi Adults
201858 citationsauthor #5
Non-HDL-C levels and residual cardiovascular risk: Do population-specific precision approaches offer advantages?
201815 citationsauthor #1
Effect of antiretroviral therapy on allele-associated Lp(a) level in women with HIV in the Women’s Interagency HIV Study[S]
20189 citationsauthor #1
Lipoprotein(a) and HIV: Allele-Specific Apolipoprotein(a) Levels Predict Carotid Intima–Media Thickness in HIV-Infected Young Women in the Women’s Interagency HIV Study
201714 citationsauthor #1
The roles of apo(a) size, phenotype, and dominance pattern in PCSK9-inhibition-induced reduction in Lp(a) with alirocumab[S]
201727 citationsauthor #1
Lipoprotein (a): impact by ethnicity and environmental and medical conditions
2016187 citationsauthor #1
遺伝学と環境:心血管代謝ち炎症リスク特性の遺伝可能性に対する民族性,年齢と性の影響
20160 citationsauthor #1
Lipoprotein(a) and apolipoprotein(a) in polycystic ovary syndrome
20167 citationsauthor #1
The unresolved mystery of high-density lipoprotein: time for a paradigm shift?
20163 citationsauthor #1
Abstract 11918: Lipoprotein(a) Predicts Subclinical Atherosclerosis in HIV-infected Young Women in the Women’s Interagency HIV Study
20160 citationsauthor #1
Lipid Lowering with Soluble Dietary Fiber
2016153 citationsauthor #2
Lifestyle Changes: Effect of Diet, Exercise, Functional Food, and Obesity Treatment, on Lipids and Lipoproteins
201556 citationsauthor #1
Table 17, Liraglutide phase III clinical trials
20150 citationsauthor #1
Table 3, Examples of Recommendations on Physical Activity and Exercise
20150 citationsauthor #1
Table 14, Lorcaserin phase III clinical trials
20150 citationsauthor #1
Table 10, Fiber Content of Selected Fruits*
20150 citationsauthor #1
Table 8, Fiber Content of Selected Vegetables*
20150 citationsauthor #1
Mediterranean diet and cardiovascular disease: a step closer to mechanisms using a precision animal model?
20150 citationsauthor #1
Correction: Attenuated Age-Impact on Systemic Inflammatory Markers in the Presence of a Metabolic Burden
20151 citationsauthor #3
Table 7, Nutrient Composition of Nuts*
20150 citationsauthor #1
Table 15, Phentermine/Topiramate phase III clinical trials
20150 citationsauthor #1
Table 6, n-3 Fatty Acid Content of Fish*
20150 citationsauthor #1
Table 1, Examples of Recommendations on Dietary Fats and Cholesterol
20150 citationsauthor #1
Diverging trajectory patterns of systemic versus vascular inflammation over age in healthy Caucasians and African-Americans.
20157 citationsauthor #1
Rhesus monkey (Macaca mulatta) lipoprotein(a) and apolipoprotein(a): high frequency of small size apolipoprotein(a) isoforms
20156 citationsauthor #1
Table 9, Fiber Content of Selected Legumes*
20150 citationsauthor #1
Table 11, Plant Sterol and Stanol Contents in Different Foods*
20150 citationsauthor #1
Attenuated Age-Impact on Systemic Inflammatory Markers in the Presence of a Metabolic Burden
20159 citationsauthor #3
Table 5, Potential Lipid Lowering Benefits of Functional Foods
20150 citationsauthor #1
Table 16, Naltrexone/Bupropion phase III clinical trials
20150 citationsauthor #1
Table 12, Fiber Content of Grains*
20150 citationsauthor #1
Study on synthesizing Mg/Al layered double hydroxides at different pHs
20142 citationsauthor #3
Significant associations between lipoprotein(a) and corrected apolipoprotein B-100 levels in African-Americans.
201420 citationsauthor #1
Genetics of Lipoprotein(a) in Relation to Coronary Heart Disease
20130 citationsauthor #1
HIV Disease Activity as a Modulator of Lipoprotein(a) and Allele-Specific Apolipoprotein(a) Levels
201332 citationsauthor #1
Apo E4 and lipoprotein-associated phospholipase A2 synergistically increase cardiovascular risk.
201235 citationsauthor #3
Lipoprotein(a): Genotype–Phenotype Relationship and Impact on Atherogenic Risk
201146 citationsauthor #1
Age as a Modulator of Inflammatory Cardiovascular Risk Factors
201132 citationsauthor #2
Differential associations of serum amyloid A and pentraxin-3 with allele-specific lipoprotein(a) levels in African Americans and Caucasians.
201112 citationsauthor #1
Enigmatic Role of Lipoprotein(a) in Cardiovascular Disease
201015 citationsauthor #2
Integrated Role of Two Apoliprotein E Polymorphisms on Apolipoprotein B Levels and Coronary Artery Disease in a Biethnic Population
201010 citationsauthor #2
Association of Lp-PLA(2) activity with allele-specific Lp(a) levels in a bi-ethnic population.
201018 citationsauthor #1
Usefulness of apolipoprotein B/apolipoprotein A-I ratio to predict coronary artery disease independent of the metabolic syndrome in African Americans.
201024 citationsauthor #1
Postprandial Lipoproteins and Cardiovascular Disease Risk in Diabetes Mellitus
201042 citationsauthor #1
Association of lipoprotein-associated phospholipase A2 with coronary artery disease in African-Americans and Caucasians.
201030 citationsauthor #3
Mulberry (Morus alba L.) leaves and their major flavonol quercetin 3-(6-malonylglucoside) attenuate atherosclerotic lesion development in LDL receptor-deficient mice.
2005207 citationsauthor #1
Predictive values of anthropometric measurements for multiple metabolic disorders in Asian populations.
200581 citationsauthor #3
Prevalence of the Metabolic Syndrome using the Modified ATP III Definitions for Workers in Japan, Korea and Mongolia
2005133 citationsauthor #5
Prevalence of the metabolic syndrome using the Third Report of the National Cholesterol Educational Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (ATP III) and the modified ATP III definitions for Japanese and Mongolians.
200569 citationsauthor #1
Biochemical and Molecular Actions of Nutrients Mulberry (Morus alba L.) Leaves and Their Major Flavonol Quercetin 3-(6-Malonylglucoside) Attenuate Atherosclerotic Lesion Development in LDL Receptor–Deficient Mice
20052 citationsauthor #1
Weight Loss and Improvement of Metabolic Syndrome by Interventional Program Based on Health Education
20043 citationsauthor #6
Overweight Japanese with body mass indexes of 23.0–24.9 have higher risks for obesity-associated disorders: a comparison of Japanese and Mongolians
2004165 citationsauthor #3
Appropriate BMI for Asian populations.
2004177 citationsauthor #3
Ethnic differences in the formation of small LDL particles in Asians: a comparison of Koreans, Japanese and Mongolians
200412 citationsauthor #3
Triglyceride levels are ethnic-specifically associated with an index of stearoyl-CoA desaturase activity and n-3 PUFA levels in Asians Published, JLR Papers in Press, February 16, 2004. DOI 10.1194/jlr.M300483-JLR200
200435 citationsauthor #6
Difficulty in losing weight by behavioral intervention for women with Trp64Arg polymorphism of the β3-adrenergic receptor gene
2003114 citationsauthor #5
日本における牛海綿状脳症(BSE)の発生をめぐる政策科学的検討
20030 citationsauthor #8
2P-0408 Development and evaluation of interventional program for metabolic syndrome based on health education and self-determination
20030 citationsauthor #6
3P-0820 Ethnical differences in the prevalence of small low-density lipoprotein particles; A comparison of Japanese and Mongolians
20030 citationsauthor #3
日本における牛海綿状脳症（ＢＳＥ）の発生をめぐる政策科学的検討
20030 citationsauthor #8
The New BMI Criteria for Asians by the Regional Office for the Western Pacific Region of WHO are Suitable for Screening of Overweight to Prevent Metabolic Syndrome in Elder Japanese Workers
2003428 citationsauthor #5
2P-0406 Difficulty in losing weight and improving metabolic parameters by behavioral intervention for women with Trp64 Arg polymorphism of the β3-adrenergic receptor gene
20030 citationsauthor #5

TIMELINE

2003 542 citations

2004 392 citations

2005 492 citations

2010 139 citations

2011 90 citations

2012 35 citations

2013 32 citations

2014 22 citations

2015 79 citations

2016 350 citations

2017 41 citations

2018 82 citations

2019 34 citations

2020 85 citations

2021 93 citations

2022 125 citations

2023 41 citations

2024 6 citations

2025 14 citations

COAUTHOR MAP

CONCEPT FOOTPRINT